Trial · NCT03402386
Results by group22
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 22
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Hb Level of Week 20 and Week 24 | MT-6548 | 11.35 | 95% Confidence Interval 10.99 to 11.70 | g/dL | |
| Hb Level at Each Assessment Time Point | MT-6548 | Baseline | 10.90 | 95% Confidence Interval 10.56 to 11.25 | g/dL |
| Hb Level at Each Assessment Time Point | MT-6548 | Week 2 | 10.96 | 95% Confidence Interval 10.54 to 11.38 | g/dL |
| Hb Level at Each Assessment Time Point | MT-6548 | Week 4 | 10.74 | 95% Confidence Interval 10.31 to 11.17 | g/dL |
| Hb Level at Each Assessment Time Point | MT-6548 | Week 6 | 10.61 | 95% Confidence Interval 10.09 to 11.13 | g/dL |
| Hb Level at Each Assessment Time Point | MT-6548 | Week 8 | 10.87 | 95% Confidence Interval 10.41 to 11.33 | g/dL |
| Hb Level at Each Assessment Time Point | MT-6548 | Week 10 | 10.89 | 95% Confidence Interval 10.45 to 11.32 | g/dL |
| Hb Level at Each Assessment Time Point | MT-6548 | Week 12 | 11.10 | 95% Confidence Interval 10.67 to 11.53 | g/dL |
| Hb Level at Each Assessment Time Point | MT-6548 | Week 16 | 11.58 | 95% Confidence Interval 11.12 to 12.04 | g/dL |
| Hb Level at Each Assessment Time Point | MT-6548 | Week 20 | 11.68 | 95% Confidence Interval 11.24 to 12.13 | g/dL |
| Hb Level at Each Assessment Time Point | MT-6548 | Week 24 | 11.39 | 95% Confidence Interval 11.00 to 11.79 | g/dL |
| Hb Level at Each Assessment Time Point | MT-6548 | Week 24 (LOCF) | 11.01 | 95% Confidence Interval 10.54 to 11.47 | g/dL |
| Percentage of Subjects With Hb Level at Each Assessment Time Point Within the Target Range During the Treatment Period | MT-6548 | Baseline | 57.1 | percentage of subjects | |
| Percentage of Subjects With Hb Level at Each Assessment Time Point Within the Target Range During the Treatment Period | MT-6548 | Week 2 | 60.0 | percentage of subjects | |
| Percentage of Subjects With Hb Level at Each Assessment Time Point Within the Target Range During the Treatment Period | MT-6548 | Week 4 | 41.5 | percentage of subjects | |
| Percentage of Subjects With Hb Level at Each Assessment Time Point Within the Target Range During the Treatment Period | MT-6548 | Week 6 | 35.9 | percentage of subjects | |
| Percentage of Subjects With Hb Level at Each Assessment Time Point Within the Target Range During the Treatment Period | MT-6548 | Week 8 | 47.4 | percentage of subjects | |
| Percentage of Subjects With Hb Level at Each Assessment Time Point Within the Target Range During the Treatment Period | MT-6548 | Week 10 | 44.7 | percentage of subjects | |
| Percentage of Subjects With Hb Level at Each Assessment Time Point Within the Target Range During the Treatment Period | MT-6548 | Week 12 | 44.7 | percentage of subjects | |
| Percentage of Subjects With Hb Level at Each Assessment Time Point Within the Target Range During the Treatment Period | MT-6548 | Week 16 | 32.4 | percentage of subjects |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03402386/results